| Feb 19 |
Ironwood Pharmaceuticals to Present at Upcoming Investor Conferences
|
| Feb 17 |
Ironwood Pharmaceuticals, Inc. 2020 Q4 - Results - Earnings Call Presentation
|
| Feb 17 |
Ironwood Pharmaceuticals, Inc.'s (IRWD) CEO Mark Mallon on Q4 2020 Results - Earnings Call Transcript
|
| Feb 17 |
Ironwood Pharmaceuticals Inc (IRWD) Q4 2020 Earnings Call Transcript
|
| Feb 17 |
Ironwood shares rise on Linzess powered fourth-quarter beat
|
| Feb 17 |
Recap: Ironwood Pharmaceuticals Q4 Earnings
|
| Feb 17 |
Ironwood Pharmaceuticals EPS beats by $0.07, beats on revenue
|
| Feb 17 |
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results, Exceeding or Meeting Full Year 2020 Financial Guidance; Provides Full Year 2021 Financial Guidance
|
| Feb 17 |
Earnings Scheduled For February 17, 2021
|
| Feb 16 |
Ironwood Pharmaceuticals Q4 2020 Earnings Preview
|
| Feb 14 |
The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week
|
| Feb 10 |
Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q4 Earnings Expected to Decline
|
| Feb 9 |
Ironwood Pharmaceuticals CEO exit may be catalyst for sale, analyst says
|
| Feb 9 |
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
|
| Feb 9 |
Ironwood CEO Steps Down Months After Clinical Trial Failure, Names Thomas McCourt As Interim Chief Executive
|
| Feb 8 |
Ironwood Pharma's CEO Mark Mallon to step down
|
| Feb 8 |
Ironwood Pharmaceuticals Announces CEO Transition
|
| Feb 8 |
Investors Aren't Entirely Convinced About Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Earnings
|
| Feb 3 |
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2020 Investor Update Call
|
| Jan 21 |
The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
|
| Jan 5 |
Ironwood Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference
|
| Dec 5 |
Ironwood (IRWD) Up 19.7% Since Last Earnings Report: Can It Continue?
|
| Dec 4 |
JAZZ's Zepzelca Combo SCLC Study Fails, Drug Still Promising
|
| Dec 3 |
Ironwood Pharmaceuticals Appoints Jay P. Shepard to Board of Directors
|
| Nov 30 |
FibroGen's (FGEN) Evrenzo Approved in Japan for Another Indication
|
